BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29432548)

  • 1. Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival.
    Pollom EL; Fujimoto DK; Han SS; Harris JP; Tharin SA; Soltys SG
    J Radiat Res; 2018 Mar; 59(suppl_1):i11-i18. PubMed ID: 29432548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma.
    Randolph DM; McTyre ER; Paulsson AK; Holmes JA; Hinson WH; Lesser GJ; Strowd R; Lo HW; Laxton AW; Tatter SB; Debinski W; Chan MD
    Clin Neurol Neurosurg; 2016 Dec; 151():73-78. PubMed ID: 27816029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
    Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in health care determine prognosis in newly diagnosed glioblastoma.
    Chandra A; Rick JW; Dalle Ore C; Lau D; Nguyen AT; Carrera D; Bonte A; Molinaro AM; Theodosopoulos PV; McDermott MW; Berger MS; Aghi MK
    Neurosurg Focus; 2018 Jun; 44(6):E16. PubMed ID: 29852776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.
    Han SJ; Rutledge WC; Molinaro AM; Chang SM; Clarke JL; Prados MD; Taylor JW; Berger MS; Butowski NA
    Neurosurgery; 2015 Aug; 77(2):248-53; discussion 253. PubMed ID: 25856113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
    Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
    J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma.
    Katsigiannis S; Krischek B; Barleanu S; Grau S; Galldiks N; Timmer M; Kabbasch C; Goldbrunner R; Stavrinou P
    Radiat Oncol; 2019 Apr; 14(1):73. PubMed ID: 31036031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
    Haque W; Verma V; Butler EB; Teh BS
    Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
    Buszek SM; Al Feghali KA; Elhalawani H; Chevli N; Allen PK; Chung C
    Sci Rep; 2020 Mar; 10(1):4926. PubMed ID: 32188907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of care and outcomes for glioblastoma in patients with poor performance status.
    Malakhov N; Lee A; Garay E; Becker DJ; Schreiber D
    J Clin Neurosci; 2018 Jun; 52():66-70. PubMed ID: 29576419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases.
    Zhu P; Du XL; Hwang LY; Lairson D; Li R; Esquenazi Y; Zhu JJ
    Sci Rep; 2023 Feb; 13(1):3266. PubMed ID: 36841851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of radiotherapy for elderly patients with glioblastoma.
    Scott J; Tsai YY; Chinnaiyan P; Yu HH
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):206-10. PubMed ID: 20675068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
    Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
    World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
    Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
    Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
    Zhu P; Du XL; Zhu JJ; Esquenazi Y
    J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.